R. Ancelle-Park

845 total citations
20 papers, 435 citations indexed

About

R. Ancelle-Park is a scholar working on Oncology, Epidemiology and Infectious Diseases. According to data from OpenAlex, R. Ancelle-Park has authored 20 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Epidemiology and 5 papers in Infectious Diseases. Recurrent topics in R. Ancelle-Park's work include Global Cancer Incidence and Screening (11 papers), Colorectal Cancer Screening and Detection (9 papers) and HIV, Drug Use, Sexual Risk (5 papers). R. Ancelle-Park is often cited by papers focused on Global Cancer Incidence and Screening (11 papers), Colorectal Cancer Screening and Detection (9 papers) and HIV, Drug Use, Sexual Risk (5 papers). R. Ancelle-Park collaborates with scholars based in France, Greece and United Kingdom. R. Ancelle-Park's co-authors include Nicolas Duport, Juliette Bloch, M. Boussac-Zarebska, Hermann Brenner, S Moss, H. Goulard, G. Papaevangelou, Clive Richardson, Zoé Uhry and B. Séradour and has published in prestigious journals such as AIDS, Endoscopy and European Journal of Epidemiology.

In The Last Decade

R. Ancelle-Park

20 papers receiving 412 citations

Peers

R. Ancelle-Park
M H Gail United States
Ta-Wen Hsu Taiwan
Neil Schlackman United States
Blythe Adamson United States
James Moore Australia
M H Gail United States
R. Ancelle-Park
Citations per year, relative to R. Ancelle-Park R. Ancelle-Park (= 1×) peers M H Gail

Countries citing papers authored by R. Ancelle-Park

Since Specialization
Citations

This map shows the geographic impact of R. Ancelle-Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Ancelle-Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Ancelle-Park more than expected).

Fields of papers citing papers by R. Ancelle-Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Ancelle-Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Ancelle-Park. The network helps show where R. Ancelle-Park may publish in the future.

Co-authorship network of co-authors of R. Ancelle-Park

This figure shows the co-authorship network connecting the top 25 collaborators of R. Ancelle-Park. A scholar is included among the top collaborators of R. Ancelle-Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Ancelle-Park. R. Ancelle-Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moss, S, R. Ancelle-Park, & Hermann Brenner. (2012). European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition – Evaluation and interpretation of screening outcomes. Endoscopy. 44(S 03). SE49–SE64. 63 indexed citations
2.
Uhry, Zoé, Guy Hédelin, Marc Colonna, et al.. (2010). Modelling the effect of breast cancer screening on related mortality using French data. Cancer Epidemiology. 35(3). 235–242. 5 indexed citations
3.
Ancelle-Park, R., B. Séradour, & Jérôme Viguier. (2010). Évolutions organisationnelles du programme national de dépistage organisé du cancer du sein, France. Revue d Épidémiologie et de Santé Publique. 58. S54–S54. 2 indexed citations
4.
Duport, Nicolas, R. Ancelle-Park, M. Boussac-Zarebska, Zoé Uhry, & Juliette Bloch. (2008). Are breast cancer screening practices associated with sociodemographic status and healthcare access? Analysis of a French cross-sectional study. European Journal of Cancer Prevention. 17(3). 218–224. 41 indexed citations
5.
Goulard, H., M. Boussac-Zarebska, R. Ancelle-Park, & Juliette Bloch. (2008). French colorectal cancer screening pilot programme: results of the first round. Journal of Medical Screening. 15(3). 143–148. 59 indexed citations
6.
Duport, Nicolas, R. Ancelle-Park, M. Boussac-Zarebska, Zoé Uhry, & Juliette Bloch. (2008). Les inégalités de recours au dépistage du cancer du sein : étude FADO-sein. Revue d Épidémiologie et de Santé Publique. 56(6). S367–S367. 8 indexed citations
7.
Ancelle-Park, R.. (2007). Que penser du dépistage mammographique à partir de 40 ans ?. Journal de Radiologie. 88(7-8). 929–931. 1 indexed citations
8.
Exbrayat, C., et al.. (2007). Evaluation of a combined screening programme for breast, cervical and colorectal cancers in France. European Journal of Cancer Prevention. 16(1). 26–35. 8 indexed citations
9.
Duport, Nicolas & R. Ancelle-Park. (2006). Do socio-demographic factors influence mammography use of French women? Analysis of a French cross-sectional survey. European Journal of Cancer Prevention. 15(3). 219–224. 41 indexed citations
10.
Séradour, B. & R. Ancelle-Park. (2006). Dépistage organisé des Cancers du Sein : peut-on comparer les résultats du programme français aux résultats internationaux ?. Journal de Radiologie. 87(9). 1009–1014. 17 indexed citations
11.
Ancelle-Park, R., et al.. (2005). Dépistage organisé du cancer du sein : le cahier des charges et son bilan après deux ans du Plan cancer. DSpace (Centre National De La Recherche Scientifique). 1 indexed citations
12.
Ancelle-Park, R., et al.. (2004). International comparison of performance measures for screening mammography: can it be done?. Journal of Medical Screening. 11(4). 187–193. 75 indexed citations
13.
Giordanella, Jean‐Pierre, et al.. (2002). [Mammography use among women aged 35 to 75 years].. PubMed. 89(11). 957–62. 5 indexed citations
14.
Schlumberger, M, Jean‐Claude Desenclos, G. Papaevangelou, Clive Richardson, & R. Ancelle-Park. (1999). Knowledge of HIV serostatus and preventive behaviour among European injecting drug users: Second study. European Journal of Epidemiology. 15(3). 207–215. 31 indexed citations
15.
Maso, Luigino Dal, Silvia Franceschi, Eva Negri, et al.. (1995). Trends of AIDS incidence in Europe and the United States. Sozial- und Präventivmedizin. 40(4). 239–265. 15 indexed citations
16.
Schwoebel, V, et al.. (1995). Factors associated with extrapulmonary tuberculosis as an AIDS-defining disease in Europe. Tubercle and Lung Disease. 76(4). 281–285. 6 indexed citations
17.
Delmas, Marie-Christine, et al.. (1995). Recent Trends in Pneumocystis carinii Pneumonia as AIDS-Defining Disease in Nine European Countries. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 9(1). 74???80–74???80. 18 indexed citations
18.
Papaevangelou, G., et al.. (1994). Knowledge, attitudes and beliefs of European injecting drug users concerning preventive measures for HIV. European Journal of Epidemiology. 10(2). 135–142. 6 indexed citations
19.
Richardson, Clive, R. Ancelle-Park, & G. Papaevangelou. (1993). Factors associated with HIV seropositivity in European injecting drug users. AIDS. 7(11). 1485–1492. 17 indexed citations
20.
Downs, Angela M., et al.. (1990). Surveillance of AIDS in the European Community. AIDS. 4(11). 1117–1124. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026